Produce Prescription Subsidy for Patients With Diabetes

Can a 12-month, $80-per-month produce prescription subsidy improve health-related outcomes for patients with type 2 diabetes who are at risk for food insecurity?In this pragmatic randomized clinical trial of 2155 individuals with type 2 diabetes, there were no clinically significant differences in cardiometabolic or health care utilization outcomes between patients who were randomized to receive the subsidy compared with a usual care control group.The trial results suggest that produce prescription subsidy alone did not improve outcomes among patients with diabetes who were at risk for food insecurity.

Corresponding Author: Connor Drake, PhD, MPA, Department of Population Health Sciences, Duke University School of Medicine, 215 Morris St, Durham, NC 27701 (connor.drake@duke.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.